Nutex Health Inc.: financial statements

NUTXNASDAQTechnology · Services-Business Services, NEC

Price

$169.22

November 16, 2026Market cap $1.2B

What Ploutos Investor adds for Nutex Health

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 16 fiscal years, from 2010
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Financial statements

Each fiscal year's income statement, balance sheet and cash flow as the company filed them, and the latest quarters.

2023–2025 fiscal years

Click a line to see it on the chart.

Revenue

+87.9% a year over 2 years

Line202320242025Average a year
Revenue $248M$480M$875M+87.9%
Gross profit $35M$196M$444M+257.1%
Operating income -$32M$131M$276M
Net income -$46M$52M$71M
Earnings per share -$10.39$9.69$10.48
Earnings per share, basic -$10.39$10.23$11.13
Margins
Gross margin 14.0%40.9%50.8%
Operating margin -12.8%27.2%31.5%
Net margin -18.5%10.9%8.1%

Financial statements

NUTX's revenue, profits and cash flows from 2010 to 2022, 13 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

By segment

Revenue and operating income by business segment or by product, as the company itself reports them in each year's 10-K. Each year from the latest filing that carries it, so a segment renamed or re-cut shows in its current form.

  • 2023: Hospital Division $218M, Population Health Management Division $30M
  • 2024: Hospital Division $449M, Population Health Management Division $31M
  • 2025: Hospital Division $844M, Population Health Management Division $31M
Segment202320242025Share 2025
Hospital Division$218M$449M$844M96%
Population Health Management Division$30M$31M$31M3.6%

By segment

NUTX's revenue by segment from 2022 to 2022, 1 more fiscal year

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 4 fiscal years.

From the XBRL of 15 of the company's annual reports to the SEC (ASC 280). Amounts in dollars.

Amounts are in dollars as the company filed them in its annual reports (10-K or 20-F). Those reporting in another currency are converted at each fiscal year-end rate. Shares and earnings per share are adjusted for splits.

Debt and obligations

What the company owes beyond the loans on its balance sheet, and when it pays, from the notes to its annual report: debt maturities, leases, pension plans, goodwill by segment, and how it gets to the tax it pays.

$20M Due within 2 years$308M Leases26.3% Effective tax rate

When the debt falls due

Dec 31, 2025

Due within 2 years

$20M

Principal of loans and bonds falling due, from the annual report dated December 31, 2025, without leases and interest. The filing

  • 2026: $14M
  • 2027: $6.0M

Leases

Dec 31, 2025

Operating leases

$32M

Finance leases

$276M

The liability is the present value of the rent still to pay, at December 31, 2025. It is not counted in the ladder's debt.

Goodwill by segment

Dec 31, 2025

Total goodwill

$14M

  • Population Health Management Division$14M100%

Goodwill is what the company paid in acquisitions above the value of what it bought, at December 31, 2025. If an acquisition earns less, the goodwill is impaired and earnings fall. The filing

$14MTotal goodwill

From the statutory to the effective tax rate, 2025

Dec 31, 2025

Statutory rate

21.0%

Effective rate

26.3%

+5.3 pts

The company paid 26.3% in tax on its profit, 5.3 points above the US federal rate (21.0%). Below, the reasons it gives.

Statutory rate

21.0%

Share-based compensation

+10.0 pts

Difference the filing does not itemize

-4.7 pts

Effective rate

26.3%

One point is 1% of profit before tax. The lines are as the company states them in the notes to its annual report. The filing

Claims ahead of shareholders

What stands between the business and its shareholders besides the debt, and the financial assets on the other side, from the latest balance sheet.

$105M ahead of the shares8.9% of market value

Besides its $365M of debt, $105M of other claims rank ahead of the shares, about 8.9% of the market value.

Ahead of the shares

at Sep 30, 2026
$105M

From the balance sheet of September 30, 2026. The retirement and environmental lines and the pension deficit come from the latest annual report when the quarter's filing does not state them, each with its own date. Market value at the price of November 16, 2026. A line is listed when it is at least 0.5% of the market value. A description of the balance sheet, not a valuation.

Earnings quality

How the reported earnings were made, read from the filings. A description, not a score: our tests found no link between these measures and later share returns.

Taxes: deferred and paid

The deferred part was 26.5% of the tax charge in the year to Dec 31, 2025. The rows show the last 2 years.

Cash taxes paid were 153.8% of the current tax charge in the year to Dec 31, 2025.

Deferred share, year to Dec 31, 2025$17M of $64M
26.5%
Deferred share, year to Dec 31, 2024-$13M of $15M
-87.4%
$73M paid, $47M current
153.8%

When profit in the accounts runs ahead of taxable profit, the deferred part grows. It also moves for reasons unrelated to how earnings are booked: tax-law changes, the use of past losses, and the US rule since 2022 that spreads research costs over five years. Where the notes report it, the tax-rate bridge under Debt and obligations shows how the rate gets from the statutory one to the effective one.

The earnings per share split is not shown: net income over the diluted share count does not match the earnings per share the company filed, so the parts would not add up to it.

Receivables and inventory against sales are not shown: a figure it needs is missing from the company's structured filings.

The allowance for doubtful accounts is not shown: the company does not tag it in its structured filings.

A reading is called out when it is above the 90th percentile of the same reading across the S&P 500, or, for a fall, below the 10th, as measured on 9 November 2026. Each part uses only the company's own filings.

The full analysis

What do Nutex Health's filings show?

These are Nutex Health's figures from its filings. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about NUTX's financials

Didn't find what you were looking for?

Ask us
How much revenue did NUTX have in 2025?

Nutex Health had revenue of $875M and net income of $71M in fiscal 2025, a net margin of 8.1%.

How much debt does NUTX have?

On December 31, 2025 Nutex Health had total assets of $919M, debt of $43M and shareholders' equity of $329M.

How much free cash flow does NUTX have?

In fiscal 2025 Nutex Health had cash from operations of $248M and spent $2.5M on capital expenditure, leaving $246M of free cash flow.

Where are the figures from?

From Nutex Health Inc.'s annual and quarterly reports to the SEC, read from the structured data (XBRL) it files itself.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.